ArticleJournal of robotic surgery2026
Comparison of short- and long-term outcomes of robotic versus laparoscopic gastrectomy for locally advanced gastric cancer after neoadjuvant immunochemotherapy: a single-center propensity score matched study.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- The learning curve of robotic esophagectomy: a systematic review with a proposed training and competency assessment framework.Frontiers in oncology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neoadjuvant immunochemotherapy (NAIC) has been confirmed to achieve greater tumor regression and better potential survival benefits than neoadjuvant chemotherapy alone. However, for locally advanced gastric cancer after NAIC, existing evidence comparing robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) remains limited. This research included 305 patients in total, among which 196 underwent LG and 109 underwent RG. After propensity score matching (PSM), 90 patients were retained in each cohort. Compared with LG, RG was associated with shorter operative duration (205.49 ± 48.49 min versus 243.27 ± 66.42 min, P < 0.001), higher total number of harvested lymph nodes (31.78 ± 12.86 versus 26.83 ± 10.71, P = 0.006), lower intraoperative blood loss (median: 20 ml versus 30 ml, P = 0.004), and lower incidence of postoperative complications (18.89% versus 37.78%, P = 0.005). Regarding survival outcomes, RG significantly improved the 3-year disease-free survival (DFS) rate (81.1% versus 66.6%, P = 0.029), while no statistically significant between-group difference was observed in 3-year overall survival (OS) (91.1% versus 83.3%, P = 0.136). In conclusion, compared with LG, RG shows clear advantages in short-term postoperative outcomes and 3-year DFS, with no significant difference in 3-year OS.
Indexed as
Identifiers
42474789What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.